BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38237393)

  • 21. 6-Aminocoumarin oxime-ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies.
    Ghouse SM; Sinha K; Bonardi A; Pawar G; Malasala S; Danaboina S; Mohammed A; Yaddanapudi VM; Supuran CT; Nanduri S
    Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300316. PubMed ID: 37495909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
    Ghorab MM; Soliman AM; Bua S; Supuran CT
    Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies.
    Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT
    Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
    Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase.
    Kakakhan C; Türkeş C; Güleç Ö; Demir Y; Arslan M; Özkemahlı G; Beydemir Ş
    Bioorg Med Chem; 2023 Jan; 77():117111. PubMed ID: 36463726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors.
    Oudah KH; Mahmoud WR; Awadallah FM; Taher AT; Abbas SE; Allam HA; Vullo D; Supuran CT
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):12-23. PubMed ID: 36305274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity.
    Abdel-Mohsen HT; Omar MA; Petreni A; Supuran CT
    Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200180. PubMed ID: 36056903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
    Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives.
    Abdel-Aziz AA; El-Azab AS; Bua S; Nocentini A; Abu El-Enin MA; Alanazi MM; AlSaif NA; Hefnawy MM; Supuran CT
    Bioorg Chem; 2019 Jun; 87():425-431. PubMed ID: 30921744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids.
    Singh P; Swain B; Thacker PS; Sigalapalli DK; Purnachander Yadav P; Angeli A; Supuran CT; Arifuddin M
    Bioorg Chem; 2020 Jun; 99():103839. PubMed ID: 32289586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
    Soliman AM; Ghorab MM; Bua S; Supuran CT
    Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
    Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
    Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of benzene and benzothiazole-sulfonamide analogues as selective inhibitors of the tumor-associated carbonic anhydrase IX.
    Manzoor S; Angeli A; Zara S; Carradori S; Rahman MA; Raza MK; Supuran CT; Hoda N
    Eur J Med Chem; 2022 Dec; 243():114793. PubMed ID: 36201858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Angeli A; Argulwar OS; Tiwari PL; Arifuddin M; Supuran CT
    Bioorg Chem; 2020 May; 98():103739. PubMed ID: 32193032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.